Ingrid E Scheffer Selected Research

Brain Diseases (Brain Disorder)

1/2022	Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies.
1/2021	ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria.
1/2021	Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial.
1/2021	The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
1/2021	Cation leak underlies neuronal excitability in an HCN1 developmental and epileptic encephalopathy.
1/2020	Defining the phenotype of FHF1 developmental and epileptic encephalopathy.
1/2020	SCN1A Variants in vaccine-related febrile seizures: A prospective study.
1/2019	Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.
1/2018	The ketogenic diet is effective for refractory epilepsy associated with acquired structural epileptic encephalopathy.
1/2017	Frequency of CNKSR2 mutation in the X-linked epilepsy-aphasia spectrum.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid E Scheffer Research Topics

Disease

79	Epilepsy (Aura) 11/2022 - 02/2002
53	Seizures (Absence Seizure) 11/2022 - 09/2002
30	Myoclonic Epilepsies (Myoclonic Encephalopathy) 11/2022 - 02/2002
25	Brain Diseases (Brain Disorder) 01/2022 - 06/2006
13	Febrile Seizures (Febrile Seizure) 11/2022 - 02/2002
13	Partial Epilepsies (Epilepsy, Partial) 02/2022 - 12/2008
11	Generalized Epilepsy 08/2019 - 02/2002
10	Epileptic Syndromes 12/2019 - 09/2002
9	Intellectual Disability (Idiocy) 01/2022 - 06/2008
8	Cognitive Dysfunction 01/2022 - 12/2011
7	Sudden Unexpected Death in Epilepsy 01/2022 - 09/2014
7	Absence Epilepsy (Childhood Absence Epilepsy) 01/2021 - 01/2003
6	Idiopathic Generalized Epilepsy 01/2021 - 05/2004
5	Drug Resistant Epilepsy 01/2022 - 03/2012
5	Neurodevelopmental Disorders 01/2022 - 01/2016
5	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy 01/2018 - 04/2003
5	Channelopathies 01/2013 - 04/2003
5	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 10/2012 - 09/2002
4	Autism Spectrum Disorder 01/2022 - 04/2007
4	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 04/2014
4	Frontal Lobe Epilepsy (Epilepsy, Supplementary Motor) 10/2018 - 08/2008
4	Temporal Lobe Epilepsy 10/2013 - 05/2005
4	Generalized Epilepsy with Febrile Seizures Plus 07/2009 - 02/2002
4	Juvenile Myoclonic Epilepsy 04/2007 - 04/2003
3	Migraine with Aura (Familial Hemiplegic Migraine) 11/2022 - 01/2009
3	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 01/2012
3	Fever (Fevers) 01/2022 - 01/2017
3	Infantile Epileptic-Dyskinetic Encephalopathy 09/2015 - 08/2002
3	Convulsions benign familial neonatal dominant form 03/2014 - 09/2002
2	Focal Cortical Dysplasia 02/2022 - 05/2015
2	Malformations of Cortical Development 02/2022 - 04/2014
2	COVID-19 01/2022 - 01/2020
2	Hamartoma 01/2022 - 01/2016
2	Neoplasms (Cancer) 01/2022 - 01/2016
2	Dystonia 12 01/2021 - 09/2012
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2021 - 08/2015
2	Spasm (Spasms) 11/2020 - 02/2015
2	Glut1 Deficiency Syndrome 09/2020 - 10/2015
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2009
2	Sleepiness 01/2019 - 01/2017
2	Fatigue 10/2018 - 01/2017
2	Ataxia (Dyssynergia) 11/2016 - 08/2015
2	Periventricular Nodular Heterotopia 08/2014 - 11/2013
2	Hippocampal Sclerosis 10/2013 - 11/2010
2	Glioma (Gliomas) 08/2007 - 04/2003
1	Symptom Flare Up 11/2022
1	Stuttering (Stammering) 10/2022

Drug/Important Bio-Agent (IBA)

27	Sodium Channels (Sodium Channel)IBA 01/2022 - 09/2002
21	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 04/2007
19	Pharmaceutical PreparationsIBA 02/2022 - 10/2013
14	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2004
11	Ion Channels (Ion Channel)IBA 01/2018 - 09/2002
7	Potassium Channels (Potassium Channel)IBA 01/2022 - 09/2002
7	VaccinesIBA 01/2022 - 06/2006
7	Immunoglobulin E (IgE)IBA 01/2021 - 05/2004
6	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022 - 09/2009
6	CannabidiolIBA 10/2021 - 01/2017
5	SodiumIBA 01/2022 - 04/2004
5	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 08/2004
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2015 - 04/2003
5	Biological ProductsIBA 04/2014 - 04/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2014
4	Glucose (Dextrose)FDA LinkGeneric 09/2020 - 02/2014
3	Voltage-Gated Sodium ChannelsIBA 11/2022 - 01/2009
3	Lacosamide FDA Link 11/2022 - 10/2018
3	Lamotrigine (Lamictal)FDA LinkGeneric 11/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
3	FenfluramineIBA 01/2022 - 11/2020
3	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 09/2012
3	Amino Acids FDA Link 01/2019 - 12/2007
3	TOR Serine-Threonine KinasesIBA 01/2016 - 04/2014
3	GABA-A Receptors (GABA(A) Receptor)IBA 04/2003 - 02/2002
2	Phenytoin (Dilantin)FDA LinkGeneric 11/2022 - 09/2015
2	Sodium Channel BlockersIBA 11/2022 - 09/2015
2	Carbamazepine (Tegretol)FDA LinkGeneric 11/2022 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2018
2	LipidsIBA 01/2022 - 01/2019
2	F-Box ProteinsIBA 01/2022 - 01/2018
2	stiripentolIBA 11/2021 - 01/2018
2	GABA Receptors (GABA Receptor)IBA 01/2021 - 08/2003
2	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 09/2012
2	Protein Isoforms (Isoforms)IBA 01/2021 - 12/2016
2	EnzymesIBA 01/2021 - 01/2018
2	CannabinoidsIBA 12/2020 - 01/2019
2	gamma-Aminobutyric Acid (GABA)IBA 08/2019 - 07/2004
2	CalciumIBA 11/2018 - 10/2017
2	Quinidine (Chinidin)FDA LinkGeneric 01/2018 - 04/2014
2	LigandsIBA 01/2018 - 07/2006
2	polyalanineIBA 09/2014 - 08/2002
2	NucleotidesIBA 09/2014 - 02/2014
2	PotassiumIBA 03/2014 - 09/2010
2	Leucine (L-Leucine)FDA Link 08/2007 - 04/2003
2	Ligand-Gated Ion ChannelsIBA 04/2007 - 08/2003
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 11/2022

Therapy/Procedure

31	Therapeutics 11/2022 - 04/2007
8	Ketogenic Diet 01/2022 - 09/2009
4	Precision Medicine 01/2022 - 01/2021
2	Speech Therapy (Therapy, Speech) 10/2022 - 12/2021
2	Induced Hyperthermia (Thermotherapy) 12/2016 - 12/2015
2	Immunotherapy 01/2012 - 05/2011